ArticleMolecular diversity2026
LightDTA: lightweight drug-target affinity prediction via random-walk network embedding and knowledge distillation.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Accurately predicting drug targeting affinity is crucial in the field of drug discovery. With the rapid development of artificial intelligence, many deep learning methods have been proposed for drug target affinity prediction tasks. However, most existing methods rely heavily on a detailed description of biochemical attributes of inputs; besides, the model architecture is getting increasingly complex just to achieve a slight performance gain. Together, these poses great challenges for real-world employments and applications. This study proposes a new lightweight framework, LightDTA, which combines knowledge distillation and random walk algorithms to predict drug target affinity. It adopts a lightweight network-based protein representation and eliminates the tedious process of collecting detailed biochemical properties. A knowledge distillation framework is further introduced to enrich molecular-level knowledge and enhance predictive capability while not affecting the model efficiency. Comprehensive experiments show that LightDTA achieves state-of-the-art performance in both classification and regression tasks, with only 61% of the memory requirements of the suboptimal baseline model. It also achieves a 7 × speedup in inference time. Therefore, the proposed method offers a highly efficient and accurate model for real-world prediction of drug-target affinities. The code for LightDTA is publicly available at: https://github.com/Huang-zilin/LightDTA-final .
Indexed as
Identifiers
41498885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.